Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Conatus Pharmaceuticals Inc. buy melinda

Start price
€10.46
02.04.19 / 50%
Target price
€19.84
30.10.19
Performance (%)
-79.93%
End price
€2.10
30.10.19
Summary
This prediction ended on 30.10.19 with a price of €2.10. The BUY prediction by melinda for Conatus Pharmaceuticals Inc. performed very badly with a performance of -79.93%. melinda has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Conatus Pharmaceuticals Inc. - - - -
iShares Core DAX® 2.594% -1.861% 13.242% 16.867%
iShares Nasdaq 100 3.553% -2.064% 38.293% 45.898%
iShares Nikkei 225® 0.687% -8.704% 17.510% 2.760%
iShares S&P 500 2.209% -1.988% 27.632% 42.955%

Comments by melinda for this prediction

In the thread Conatus Pharmaceuticals Inc. diskutieren
Prediction Buy
Perf. (%) -79.93%
Target price 1.984
Change
Ends at 30.10.19

Secteur Recherche biotechnologique et médicale Agenda 13/04 | 16:00


    


    


    


    


    


     13/04/19 | 16h00   Congrès international du foie 05.06.19   T1 2019 Publication de résultats (estimation) 05.08.19   Premier semestre 2019 Publication de résultats (estimation) 11.11.19   T3 2019 Publication de résultats (estimation)

Prediction Buy
Perf. (%) -79.93%
Target price 1.984
Change
Ends at 30.10.19

Buy closed

Stopped prediction by melinda for Conatus Pharmaceuticals Inc.

buy
Conatus Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€14.61
11.12.18
€27.06
09.01.19
29.63%
09.01.19

buy
Conatus Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€35.45
06.12.17
€36.98
08.12.17
4.83%
08.12.17

buy
Conatus Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€43.48
06.02.17
€49.61
30.03.17
5.62%
30.03.17